Abstract:Background and aim: Hypoxia invariably develops as solid tumors enlarge, and there are unique cellular adaptations to ensure tumor survival in these conditions.Our previous work demonstrated a key role for K-RAS in the induction of angiogenic factors VEGF and IL-8 in hypoxic conditions.We have identified adrenomedullin (ADM) as a novel target of K-RAS in hypoxia and sought to determine its functional role in CRC.Methods: We performed cDNA microarray studies using DKS-5 cells with a K-RAS (D13) mutation and DKO-3 cells in which the mutant K-RAS oncogene was knocked-out.ADM expression was verified by Q-PCR and ELISA in CRC cells by knocking-down or overexpressing mutant K-RAS.ADM expression in 56 human colorectal tumors (K-RAS mutant=14, WT=42) was evaluated by immunohistochemistry.The functional roles on cell migration, invasion, and proliferation were determined after exogenous administration of ADM peptide or siRNA knockdown of ADM In Vitro.Results: Microarrays demonstrated that ADM was significantly upregulated in mutant K-RAS (D13) cells relative to isogenic WT K-RAS cells in hypoxic conditions.qPCR and ELISA assays confirmed the induction of ADM mRNA (17 fold) and protein (4.5 fold) by the combination of K-RAS and hypoxia.The hypoxic induction of ADM was reduced 70-89% when K-RAS was knocked-down in DLD1, HCT116, and SW480 cell lines.Stable expression of mutant K-RAS in Caco2 cells induced ADM expression 2.4 fold.The induction of ADM by K-RAS and hypoxia depended upon HIF-1, as this induction was blocked by knockdown of HIF-1alpha.In addition, inhibition of PI3K but not MEK1 suppressed the induction both HIF-1 and ADM in hypoxic conditions.Administration of 200 nmol/L ADM stimulated migration (217% ± 42%, p<0.001), invasion (195% ± 4.0%, p<0.001) and proliferation (146% ± 6.0%, p<0.01) of SW480 cells.Interestingly, ADM induced VEGF levels 1.5 fold, and knockdown of ADM suppressed VEGF levels to 32% of baseline.Finally, a significant correlation was observed between ADM protein staining and the K-RAS genotype in human CRC samples, with moderate to strong staining of ADM seen in 71% of K-RAS mutant tumors vs. 40% of K-RAS WT tumors (p<0.05).Conclusion: Adrenomedullin is a novel target of K-RAS and hypoxia in colon cancer.K-RAS regulates the hypoxic induction of ADM through the PI3K and HIF-1 pathways.In addition to stimulating colon cancer cell invasion and growth, ADM can regulate angiogenesis through the induction of VEGF.Collectively, these findings highlight the importance of K-RAS and ADM in colon tumor survival in hypoxic conditions.

Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion

Adrenomedullin is a Novel K-RAS Target Gene That Regulates Cellular Invasion and Angiogenesis in Hypoxia

Adrenomedullin Is Expressed in Pancreatic Cancer and Stimulates Cell Proliferation and Invasion in an Autocrine Manner via the Adrenomedullin Receptor, ADMR

Adrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells

The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment

Adrenomedullin: A Tumor Progression Factor via Angiogenic Control

The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma

Integrated Bioinformatics Analysis Identified COL11A1 As an Immune Infiltrates Correlated Prognosticator in Pancreatic Adenocarcinoma

Adrenomedullin is a therapeutic target in colorectal cancer

Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth

Adrenomedullin and cancer

Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice

Adrenomedullin is involved in the progression of colonic adenocarcinoma

Regulation and Neutralisation of Adrenomedullin in Cancer

Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor

Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis

Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia

Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition

Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo

Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells